Comparison
Citicoline vs Creatine Monohydrate
Side-by-side of Citicoline and Creatine Monohydrate. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
Citicoline
Citicoline supplement profile: CDP-choline as a phosphatidylcholine precursor, Cognizin dosing 250-2000 mg, cognition trials, stroke recovery evidence.
Creatine Monohydrate
Creatine monohydrate supplement guide: 3-5 g/day raises phosphocreatine stores, lifts anaerobic output 5-15%, supports lean mass and cognition under sleep loss.
Effects at a glance
Citicoline
- •Choline donor and phosphatidylcholine precursor; oral bioavailability roughly 99%
- •Standard prescription medication for stroke recovery and vascular cognitive impairment in much of the world
- •Healthy-adult cognitive trials (Cognizin) report small gains in attention and working memory at 250 to 500 mg/day
- •ICTUS trial (n=2,298) was negative on stroke recovery in the modern thrombolysis era
- •Lower per-gram choline content than alpha-GPC (~18% vs ~40%), meaning smaller TMAO load at equivalent dose
- •Long uridine half-life (~56 hours) supports once or twice daily dosing
Creatine Monohydrate
- •Increases anaerobic strength and power output by ~5 to 15% across multiple training studies
- •Adds ~1 to 2 kg of lean body mass over 4 to 12 weeks, partly intracellular water and partly true tissue gain
- •Improves 1-rep max on bench and squat by ~5 to 10% versus placebo in resistance-trained adults
- •Cognitive benefit appears mainly under sleep deprivation or high mental load, less so in well-rested individuals
- •Saturation reached in ~28 days at 3 to 5 g/day, or ~5 to 7 days with a 20 g/day loading phase
- •No evidence of renal harm in healthy adults across long-term studies; caution in pre-existing severe renal disease
Side-by-side
| Attribute | Citicoline | Creatine Monohydrate |
|---|---|---|
| Category | supplement | supplement |
| Also known as | CDP-choline, cytidine 5'-diphosphocholine, Cognizin | creatine |
| Half-life (hr) ↗ | 56 | 3 |
| Typical dose (mg) ↗ | 500 | 5000 |
| Dosing frequency | 1 to 2 times daily | daily |
| Routes | oral, intravenous | oral |
| Onset (hr) | 1 | 168 |
| Peak (hr) | 2 | - |
| Molecular weight | 488.32 | 149.15 |
| Molecular formula | C14H26N4O11P2 | C4H9N3O2 |
| Mechanism | Hydrolyzed to cytidine and choline after absorption; both cross the blood-brain barrier and are recombined intracellularly to reform CDP-choline, supporting phosphatidylcholine synthesis and acetylcholine production. | Donates a phosphate group to ADP via creatine kinase, regenerating ATP during high-intensity, short-duration efforts. |
| Legal status | Dietary supplement (US, Cognizin GRAS); prescription medication in most of the world | Dietary supplement (most jurisdictions) |
| WADA status | allowed | allowed |
| DEA / Rx | OTC supplement (US); Rx in most of the world | OTC supplement |
| Pregnancy | Insufficient data for routine use | Insufficient data |
| CAS | 987-78-0 | 57-00-1 |
| PubChem CID | 13804 | 586 |
| Wikidata | Q411470 | Q408389 |
Safety profile
Citicoline
Common side effects
- mild GI upset
- headache
- restlessness
- occasional insomnia with evening dosing
Contraindications
- concurrent strong anticholinergic therapy
- established cardiovascular disease (TMAO concern, smaller than alpha-GPC)
Interactions
- anticholinergic medications: partial mutual antagonism(minor)
- cholinesterase inhibitors: additive cholinergic effect(minor)
- antimetabolite chemotherapy (5-FU): theoretical cytidine pathway interaction(minor)
Creatine Monohydrate
Common side effects
- water retention
- mild GI upset at loading doses
- weight gain (2 to 4 lb from intracellular water)
Contraindications
- severe renal impairment
Interactions
- caffeine (high-dose acute): mixed data on ergogenic interference; chronic use appears compatible(minor)
- nephrotoxic drugs (NSAIDs, cyclosporine): theoretical additive renal strain in at-risk patients(moderate)
Which Should You Take?
Creatine Monohydrate comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-A outcome catalogued. Citicoline is the right call when one of the conditionals below applies.
- → If your priority is stroke recovery, pick Citicoline.
- → If your priority is choline supply, pick Citicoline.
- → If your priority is strength or hypertrophy, pick Creatine Monohydrate.
- → If your priority is post-training recovery, pick Creatine Monohydrate.
Edge case: Half-lives differ materially (Citicoline ~56 hr vs Creatine Monohydrate ~3 hr). Citicoline reaches steady state faster; Creatine Monohydrate is easier to dial in if tolerability is uncertain.
Default choice: Creatine Monohydrate. Lower friction to source, a Tier-A evidence outcome catalogued, and broader goal coverage. Reach for Citicoline only if your priority sits squarely in the goals it owns above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between Citicoline and Creatine Monohydrate?
Citicoline and Creatine Monohydrate differ in category (supplement vs supplement), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, Citicoline or Creatine Monohydrate?
Citicoline half-life is 56 hours; Creatine Monohydrate half-life is 3 hours.
Can you stack Citicoline with Creatine Monohydrate?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper